Modeling anxiety-like states: Pharmacological characterization of the chick separation stress paradigm

Behavioural Pharmacology

Volumn 17, Issue 7, 2006, Pages 581-587

  Warnick, Jason E ^a   Wicks, Robert T ^a   Sufka, Kenneth J ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Animal model; Anxiety; Anxiolytic screen; Chick separation stress paradigm; Domestic fowl; Separation stress; Validation

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMPHETAMINE; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CAFFEINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLONIDINE; DIMETHYL SULFOXIDE; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; MEPROBAMATE; PENTOBARBITAL; PHENELZINE; SCOPOLAMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CHICK; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG EFFICACY; GENERALIZED ANXIETY DISORDER; NEWBORN; NONHUMAN; PANIC; SEDATION; SEPARATION ANXIETY; SLEEP; TRANQUILIZING ACTIVITY; VOCALIZATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; ANXIETY, SEPARATION; CHICKENS; DISEASE MODELS, ANIMAL; MALE; MODELS, PSYCHOLOGICAL; PANIC DISORDER; STRESS, PSYCHOLOGICAL; VOCALIZATION, ANIMAL;

EID: 33749514950     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000236269.87547.9d     Document Type: Article

References (51)

1. Baldauf K, Braun K, Gruss M (2005). Opiate modulation of monoamines in the chick forebrain: possible role in emotional regulation? J Neurobiol 62:149-163.
2. Baldwin HA, Johnston AL, File SE (1989). Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol 159:211-215.
3. Benton D, Nastiti K (1988). The influence of psychotropic drugs on the ultrasonic calling of mouse pups. Psychopharmacology 95:99-102.
4. Buigues J, Vallejo J (1987). Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks. J Clin Psychiatry 48:55-59.
5. Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, et al. (1986). Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J Clin Psychiatry 47:580-586.
6. Charney DS, Woods SW, Goodman WK, Heninger GR (1987). Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144:1030-1036.
7. Charney DS, Woods SW, Heninger GR (1989). Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res 27:173-182.
8. Chouinard G, Annable L, Fontaine R, Solyom L (1982). Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology 77:229-233.
9. Cole JC, Rodgers RJ (1994). Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114:288-296.
10. Collias NE, Joos M (1953). The spectrographic analysis of sound signals of the domestic fowl. Behaviour 5:175-189.
11. Davidson JRT, Connor KM (2004). Treatment of anxiety disorders. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmcology. 3rd ed. Washington, DC: American Psychiatric Publishing. pp. 913-934.
12. De Vry J, Benz U, Schreiber R, Traber J (1993). Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol 249:331-339.
13. Feltenstein MW, Ford NG, Freeman KB, Sufka KJ (2002). Dissociation of stress behaviors in the chick social-separation-stress procedure. Physiol Behav 75:675-679.
14. Feltenstein MW, Lambdin LC, Ganzera M, Dharmaratne HRW, Nanayakkara NPD, Khan IA, Sufka KJ (2003a). Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother Res 17:210-216.
15. Feltenstein MW, Lambdin LC, Webb HE, Warnick JE, Khan SI, Khan IA, et al. (2003b). Corticosterone response in the chick separation-stress paradigm. Physiol Behav 78:489-493.
16. Feltenstein MW, Warnick JE, Guth AN, Sufka KJ (2004). The chick separation stress paradigm: a validation study. Pharmacol Biochem Behav 77:221-226.
17. Feltenstein MW, Sufka KJ (2005). Screening antidepressants in the chick separation-stress paradigm. Psychopharmacology 181:153-159.
18. File SE (1990). New strategies in the search for anxiolytics. Drug Des Deliv 5:195-201.
19. Fish EW, Sekinda M, Ferrari PF, Dirks A, Miczek KA (2000). Distress vocalizations in maternally-separated mouse pups: modulation via 5HT1A, 5HT1B and GABA receptors. Psychopharmacology 149:277-285.
20. Gallup GG, Suarez SD (1980). An ethological analysis of open field behaviour in chickens. Anim Behav 28:368-378.
21. Gower AJ, Tricklebank MD (1988). Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Eur J Pharmacol 155:129-137.
22. Graeff FG, Netto CF, Zangrossi H Jr (1998). The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23:237-246.
23. Hansen S (1993). Effect of clonidine on the responsiveness of infant rats to maternal stimuli. Psychopharmacology 111:78-84.
24. Himmelhoch JM (1998). Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues. J Affect Disord 50:203-213.
25. Hoehn-Saric R, Merchant AF, Keyser ML, Smith VK (1981). Effects of clonidine on anxiety disorders. Arch Gen Psychiatry 38:1278-1282.
26. Jacobson AF, Dominguez RA, Goldstein BJ, Steinbook RM (1985). Comparison of buspirone and diazepam in generalized anxiety disorder. Pharmacotherapy 5:290-296.
27. Mason P, Skinner J, Luttinger D (1987). Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants. Psychopharmacology 92:30-34.
28. Molewijk HE, van der Poel AM, Mos J, van der Heyden JA, Olivier B (1995). Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology 117:32-40.
29. Ninan PT, Muntasser S (2004). Buspirone and gepirone. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmcology. 3rd ed. Washington, DC: American Psychiatric Publishing. pp. 391-404.
30. Panksepp J (1998). Affective neuroscience: the foundations of human and animal emotions. London: Oxford University Press.
31. Panksepp J (2003). Can anthropomorphic analyses of 'separation cries' in other animals inform us about the emotional nature of social loss in humans? Psychol Rev 110:376-388.
32. Panksepp J, Vilberg T, Bean NJ, Coy DH, Kastin AJ (1978). Reduction of distress vocalization in chicks by opiate-like peptides. Brain Res Bull 3:663-667.
33. Panksepp J, Bean NJ, Bishop P, Vilberg T, Sahley TL (1980a). Opioid blockade and social comfort in chicks. Pharmacol Biochem Behav 13:673-683.
34. Panksepp J, Meeker R, Bean NJ (1980b). The neurochemical control of crying. Pharmacol Biochem Behav 12:437-443.
35. Panksepp J, Lensing P, Leboyer M, Bouvard MP (1991). Naltrexone and other potential new pharmacological treatments of autism. Brain Dysfunction 4:281-300.
36. Rickels K, Downing R, Schweizer E, Hassman H (1993). Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 50:884-895.
37. Rossi J, Sahley TL, Panksepp J (1983). The role of brain norepinephrine in clonidine suppression of isolation-induced distress in the domestic chick. Psychopharmacology 79:338-342.
38. Sanger DJ (1990). Effects of buspirone and related compounds on suppressed operant responding in rats. J Pharmacol Exp Ther 254:420-426.
39. Sheehan DV, Raj AB, Sheehan KH, Soto S (1990). Is buspirone effective for panic disorder? J Clin Psychopharmacol 10:3-11.
40. Smith KK, Dharmaratne HRW, Feltenstein MW, Broom SL, Roach JT, Nanayakkara NPD, et al. (2001). Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology 155:86-90.
41. Stephens DN, Andrews JS (1991). Screening for anxiolytic drugs. In: Willner P, editor. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge: Cambridge University Press. pp. 50-75.
42. Sufka KJ, Weed NC (1994). Construct validation of behavioral indices of isolation stress and inflammatory nociception in young domestic fowl. Physiol Behav 55:741-746.
43. Sufka KJ, Hughes RA, McCormick TM, Borland JL (1994). Opiate effects on isolation stress in domestic fowl. Pharmacol Biochem Behav 49:1011-1015.
44. Sufka KJ, Roach JT, Chambliss WG Jr, Broom SL, Feltenstein MW, Wyandt CM, Zeng L (2001). Anxiolytic properties of botanical extracts in the chick social separation-stress procedure. Psychopharmacology 153:219-224.
45. Vilberg TR, Panksepp J, Kastin AJ, Coy DH (1984). The pharmacology of endorphin modulation of chick distress vocalization. Peptides 5:823-827.
46. Vivian JA, Barros HM, Manitiu A, Miczek KA (1997). Ultrasonic vocalizations in rat pups: Modulation at the gamma-aminobutyric acid A receptor complex and the neurosteroid recognition site. J Pharmacol Exp Ther 282:318-325.
47. Warnick JE, McCurdy CR, Sufka KJ (2005). Opioid receptor function in social attachment in young domestic fowl. Behav Brain Res 160:277-285.
48. Watson GS, Sufka KJ (1996). Chlordiazepoxide reverses social-separation-induced distress vocalizations and analgesia in young domestic fowl. Exp Clin Psychopharmacol 4:347-353.
49. Watson GS, Roach JT, Sufka KJ (1999). Benzodiazepine receptor function in the chick social-separation-stress procedure. Exp Clin Psychopharmacol 7:83-89.
50. Willner P (1991). Behavioural models in psychopharmacology. In: Willner P, editor. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge: Cambridge University Press; pp. 3-18.
51. Witkin JM, Mansbach RS, Barrett JE, Bolger GT, Skolnick P, Weissman B (1987). Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons. J Pharmacol Exp Ther 243:970-977.